CDKN2A and neoplasm: Consistent with known genomic hallmark of PXA, the loss in short arm of the chromosome 9 associated with homozygous 9p21.3 deletion involving CDKN2A/B locus was identified in both the original patient’s tumor and the PDX sample (Fig. 5C).